Pediatric emergency medicine trisk 1321 1321
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (72.28 KB, 1 trang )
Br J Dermatol 2012;167:424–432.
Hung SI, Chung WH, Liou LB, et al. HLA-B*5801 allele as a genetic marker for
severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci
U S A 2005;102:4134–4139.
Lee HY, Lim YL, Thirumoorthy T, et al. The role of intravenous immunoglobulin
in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed
in a specialized centre. Br J Dermatol 2013;169:1304–1309.
Mallal S, Nolan D, Witt C, et al. Association between presence of HLA-B*5701,
HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase
inhibitor abacavir. Lancet 2002;359:727–732.
Sassolas B, Haddad C, Mockenhaupt M, et al. ALDEN, an algorithm for
assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal
necrolysis: comparison with case-control analysis. Clin Pharmacol Ther
2010;88:60–68.
Wootton CI, Patel AN, Williams HC. In a patient with toxic epidermal necrolysis,
does intravenous immunoglobulin improve survival compared with supportive
care? Arch Dermatol 2011;147:1437–1440.
